GlassScriptPhysician profile
Meryl Blecker-Joerg
NPI 1932109014
$9,335.31
in general payments reported to CMS, 2019-2025
32 companies · $2,163 in 2025
The $2,163 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,607 · 2020: $764 · 2021: $276 · 2022: $813 · 2023: $2,104 · 2024: $1,607 · 2025: $2,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,874.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $1,515.93 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $1,513.43 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $1,291.74 | 2019-2025 | Nemluvio, Aklief |
| Pfizer INC. | $1,189.64 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $953.78 | 2019-2025 | Cabtreo, Jublia |
| Ucb, INC. | $389.33 | 2019-2025 | Bimzelx |
| Incyte Corporation | $321.80 | 2021-2025 | Opzelura, Opzelura |
| Genzyme Corporation | $222.96 | 2021-2025 | |
| Merz North America, INC. | $183.52 | 2023 | |
| Dermira, INC. | $173.41 | 2019-2021 | |
| Botanix Sb INC | $172.61 | 2025 | Sofdra |
| Almirall LLC | $140.52 | 2021-2024 | Klisyri |
| Regeneron Healthcare Solutions, INC. | $135.47 | 2020-2022 | |
| Journey Medical Corporation | $124.85 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $120.24 | 2022-2024 | Sotyktu |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $92.58 | 2020-2024 | Olumiant |
| Prugen, INC. Pharmaceuticals | $87.53 | 2019 | |
| Encore Dermatology INC. | $75.28 | 2019-2020 | |
| Verrica Pharmaceuticals INC. | $72.55 | 2023-2024 | Ycanth |
| Sandoz INC. | $62.96 | 2019-2020 | |
| Janssen Biotech, INC. | $61.25 | 2022-2023 | Simponi, Stelara, Remicade |
| Organon LLC | $59.63 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $59.10 | 2023 | Winlevi, Absorica Ld |
| Sanofi-Aventis U.S. LLC | $56.94 | 2020-2025 | |
| Amgen INC. | $50.45 | 2025 | Otezla |
| Mission Pharmacal Company | $42.65 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $42.06 | 2021 | |
| Abbvie INC. | $36.26 | 2025 | |
| Leo Pharma INC. | $32.83 | 2022 | |
| Vyne Pharmaceuticals INC. | $25.73 | 2020 | |
| Strata Skin Sciences, INC. | $14.77 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meryl Blecker-Joerg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.